Wise, Mark G. http://orcid.org/0000-0001-7356-1851
Karlowsky, James A.
Mohamed, Naglaa
Kamat, Shweta
Sahm, Daniel F.
Article History
Received: 18 May 2023
Accepted: 19 July 2023
First Online: 1 August 2023
Declarations
:
: Ethical approval was not required because all isolates received into the study followed multiple subcultures and were completely de-identified. The secondary research use of de-identified isolates is considered exempt research according to the Regulations for the Protection of Human Subjects in Research of the U.S. Department of Health and Human Services, Office for Human Research Protections (45 CFR 46).
: Not applicable.
: Not applicable.
: MGW and DFS are employees of IHMA, who were paid consultants to Pfizer in connection with the development of this manuscript. JAK is a consultant to IHMA. MGW, DFS, and JAK do not have a personal financial interest in the sponsor of this work (Pfizer, Inc.). NM and SK are employees of Pfizer.